Llwytho...
Profile of a Novel Anionic Fluoroquinolone—Delafloxacin
Fluoroquinolones have been in clinical use for over 50 years with significant efficacy. However, increasing resistance and emergence of some marked adverse events have limited their usage. The most recently approved class member, delafloxacin, is the only available anionic (non-zwitterionic) fluoroq...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Infect Dis |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452001/ https://ncbi.nlm.nih.gov/pubmed/30957164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy1079 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|